Abstract: Background: Bevacizumab is one of the anti vascular endothelial growth factor (anti-VEGF) agents which has antiangiogenic and oedema-diminishing actions. It is used widely as an intravitreal solution to diminish new vessels formation and reduce the oedema of the ocular diseases. Objectives: to evaluate the safety of an intravitreal injection of bevacizumab on the cerebral cortex of rat. Material and ... إقراء المزيد